Cancer Research Cell Death Mechanisms and Cancer Therapy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, K.-i.
Right arrow Articles by Okamoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, K.-i.
Right arrow Articles by Okamoto, T.
[Cancer Research 60, 3978-3984, July 15, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Cimetidine Inhibits Cancer Cell Adhesion to Endothelial Cells and Prevents Metastasis by Blocking E-selectin Expression1

Ken-ichi Kobayashi, Sumio Matsumoto, Takashi Morishima, Takumi Kawabe and Takashi Okamoto2

Department of Molecular Genetics, Nagoya City University Medical School, Nagoya 467-8601 [K-i. K., T. M., T. K., T. O.], and Department of Surgery, 2nd Teaching Hospital, Fujita Health University Medical School, Nagoya 454-8509 [K-i. K., T. M., S. M.], Japan

Although the beneficial effect of cimetidine on survival in cancer has been clinically demonstrated in colorectal cancer patients, the mode of action of cimetidine has not been elucidated. In this report, we have demonstrated for the first time that cimetidine can block the adhesion of a colorectal tumor cell line to the endothelial cell monolayer in cell culture and that it can suppress the metastasis of the tumor cell in a nude mouse model. We also demonstrated that these antimetastasis effects of cimetidine might occur through down-regulation of the cell surface expression of E-selectin on endothelial cells, a ligand for sialyl Lewis antigens on tumor cells. We found that the cimetidine-mediated down-regulation of E-selectin did not involve down-regulation of E-selectin mRNA or blocking of the nuclear translocation of nuclear factor {kappa}B, a transcriptional activator of E-selectin gene expression. Because two other histamine type 2 receptor antagonists, famotidine and ranitidine, did not show any similar effect, these actions of cimetidine probably do not occur via blocking of the histamine receptor. These observations support the idea that cancer metastasis can be blocked by cimetidine administration through blocking the adhesion of tumor cells to the endothelium when an interaction between E-selectin and sialyl-Lewis antigens plays a role.




This article has been cited by other articles:


Home page
BloodHome page
H. Laubli, K.-S. Spanaus, and L. Borsig
Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes
Blood, November 12, 2009; 114(20): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Auguste, L. Fallavollita, N. Wang, J. Burnier, A. Bikfalvi, and P. Brodt
The Host Inflammatory Response Promotes Liver Metastasis by Increasing Tumor Cell Arrest and Extravasation
Am. J. Pathol., May 1, 2007; 170(5): 1781 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Gout, C. Morin, F. Houle, and J. Huot
Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation.
Cancer Res., September 15, 2006; 66(18): 9117 - 9124.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Cianchi, C. Cortesini, N. Schiavone, F. Perna, L. Magnelli, E. Fanti, D. Bani, L. Messerini, V. Fabbroni, G. Perigli, et al.
The Role of Cyclooxygenase-2 in Mediating the Effects of Histamine on Cell Proliferation and Vascular Endothelial Growth Factor Production in Colorectal Cancer
Clin. Cancer Res., October 1, 2005; 11(19): 6807 - 6815.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A.-M. Khatib, L. Fallavollita, E. V. Wancewicz, B. P. Monia, and P. Brodt
Inhibition of Hepatic Endothelial E-Selectin Expression by C-raf Antisense Oligonucleotides Blocks Colorectal Carcinoma Liver Metastasis
Cancer Res., October 1, 2002; 62(19): 5393 - 5398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ando, T. Kawabe, H. Ohara, B. Ducommun, M. Itoh, and T. Okamoto
Involvement of the Interaction between p21 and Proliferating Cell Nuclear Antigen for the Maintenance of G2/M Arrest after DNA Damage
J. Biol. Chem., November 9, 2001; 276(46): 42971 - 42977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Laferriere, F. Houle, M. M. Taher, K. Valerie, and J. Huot
Transendothelial Migration of Colon Carcinoma Cells Requires Expression of E-selectin by Endothelial Cells and Activation of Stress-activated Protein Kinase-2 (SAPK2/p38) in the Tumor Cells
J. Biol. Chem., August 31, 2001; 276(36): 33762 - 33772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.